These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944 [TBL] [Abstract][Full Text] [Related]
7. The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial. Rodrigo R; Hasson D; Prieto JC; Dussaillant G; Ramos C; León L; Gárate J; Valls N; Gormaz JG Trials; 2014 May; 15():192. PubMed ID: 24885600 [TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT; J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907 [TBL] [Abstract][Full Text] [Related]
10. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966 [TBL] [Abstract][Full Text] [Related]
11. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial. Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442 [TBL] [Abstract][Full Text] [Related]
12. Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: results of the randomized Intra-Co-EpoMI trial. Roubille F; Micheau A; Combes S; Thibaut S; Souteyrand G; Cayla G; Bonello L; Lesavre N; Sportouch-Dukhan C; Klein F; Berboucha S; Cade S; Cung TT; Raczka F; Macia JC; Gervasoni R; Cransac F; Leclercq F; Barrère-Lemaire S; Paganelli F; Mottref P; Vernhet Kovacsik H; Ovize M; Piot C Arch Cardiovasc Dis; 2013 Mar; 106(3):135-45. PubMed ID: 23582675 [TBL] [Abstract][Full Text] [Related]
13. The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention. Suh JW; Chung WY; Kim YS; Kim KI; Jeon EJ; Cho YS; Youn TJ; Chae IH; Kim CH; Choi DJ Int J Cardiol; 2011 Jun; 149(2):216-220. PubMed ID: 20199815 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of mitochondrial permeability transition pore opening: translation to patients. Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132 [TBL] [Abstract][Full Text] [Related]
15. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention. Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885 [TBL] [Abstract][Full Text] [Related]
16. Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials. Song K; Wang S; Qi D Oxid Med Cell Longev; 2015; 2015():287058. PubMed ID: 26167239 [TBL] [Abstract][Full Text] [Related]
17. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078 [TBL] [Abstract][Full Text] [Related]
18. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339 [TBL] [Abstract][Full Text] [Related]
19. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. Thuny F; Lairez O; Roubille F; Mewton N; Rioufol G; Sportouch C; Sanchez I; Bergerot C; Thibault H; Cung TT; Finet G; Argaud L; Revel D; Derumeaux G; Bonnefoy-Cudraz E; Elbaz M; Piot C; Ovize M; Croisille P J Am Coll Cardiol; 2012 Jun; 59(24):2175-81. PubMed ID: 22676937 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporine before PCI in Patients with Acute Myocardial Infarction. Cung TT; Morel O; Cayla G; Rioufol G; Garcia-Dorado D; Angoulvant D; Bonnefoy-Cudraz E; Guérin P; Elbaz M; Delarche N; Coste P; Vanzetto G; Metge M; Aupetit JF; Jouve B; Motreff P; Tron C; Labeque JN; Steg PG; Cottin Y; Range G; Clerc J; Claeys MJ; Coussement P; Prunier F; Moulin F; Roth O; Belle L; Dubois P; Barragan P; Gilard M; Piot C; Colin P; De Poli F; Morice MC; Ider O; Dubois-Randé JL; Unterseeh T; Le Breton H; Béard T; Blanchard D; Grollier G; Malquarti V; Staat P; Sudre A; Elmer E; Hansson MJ; Bergerot C; Boussaha I; Jossan C; Derumeaux G; Mewton N; Ovize M N Engl J Med; 2015 Sep; 373(11):1021-31. PubMed ID: 26321103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]